BSD deploys hyperthermia system in China

Liuan People's Hospital in Liuan City, China, has purchased a BSD-2000 hyperthermia system from BSD Medical Systems.

The new BSD-2000 delivers precision-focused radiofrequency (RF) energy into cancerous tumors, including those located deep in the body. The RF energy raises the tumor temperature to levels used to administer hyperthermia therapy and destroy cancer cells and can increase the effectiveness of radiation therapy.

Liuan People's Hospital plans to treat cervical cancer and other pelvic cancers as well as to conduct research on the treatment of lung cancer with the new BSD-2000 system, which is restricted to investigational use in the United States.


Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.